🟢 Azitra is trading 0.16% up in pre-market with no new catalyst identified

Azitra is trading 0.16% up at $0.13, essentially unchanged from the August 19, 2026 close, with no new company-specific catalyst identified for August 20, 2026.

• The latest update was its August 12, 2026 Q2 report, including continued ATR-04 enrollment and ATR-COSF preclinical data; it is not new enough to clearly explain the move.
• XBI is up 2.27% pre-market, but Azitra is not meaningfully participating in the sector move.